Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the average analyst EPS estimate compiled by FactSet of $2.68.

C.J. Gardner-Johnson said he "retracts" the comments he made about the Philadelphia Eagles after he was traded to the Houston Texans this offseason, when he said the team "probably won't see a ring without me.

The move will occur in phases by the end of 2026, the company announced July 15. No jobs are being eliminated.

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68. The pharmaceutical giant reported sales of $23.

In March, the Eagles traded Gardner-Johnson and a 2026 sixth-round draft pick to the Texans in exchange for guard Kenyon Green and a 2025 fifth-round draft pick. Last month, Gardner-Johnson said he felt highly disrespected by the trade but understood the business aspect of the decision.

Johnson shared yet another personal insight that nobody asked for: His jizz has substantially more microplastics in it than his blood does. On X on Tuesday, Johnson posted: “I have microplastics in my ejaculate.

Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised full-year 2025 sales guidance by $2 billion and adjusted EPS guidance by $0.

The S&P 500 ticked 0.3% higher on Wednesday, July 16, 2025, as President Trump sought to ease concerns that a dismissal of Fed Chair Jerome Powell could be imminent.